Author:
Matsuo H.,Sakamoto H.,Arizono K.,Shinohara R.
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Pollution,Toxicology,General Medicine
Reference10 articles.
1. Azuma Y (2008) Environmental risk of pharmaceuticals and the industry’s thoughts on risk management. J Water Waste 50(7):99–105 [in Japanese]
2. Fick J, Lindberg LH, Tysklind M, Haemig PD, Waldenström J, Wallensten A, Olsen B (2007) Antiviral Oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza a virus 2(10): e986
3. Ghosh GC, Nakada N, Yamashita N, Tanaka H (2010) Oseltamivir carboxylate, the active metabolite of Oseltamivir phosphate (Tamivir), detected in sewage discharge and river water in Japan. Environ Health Perspect 118(1):103–107
4. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. Streams, 1999–2000: National reconnaissance. Environ Sci Technol 36(6):1202–1211
5. Narumiya M, Okuda T, Nakata N, Yamashita N, Tanaka H, Sato K, Sueoka M, Ooiwa T (2009) Actual behavior and the presence of pharmaceuticals in sewage treatment process. Environ Eng Res Arch 46:175–186 [in Japanese]
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献